Table of Contents
Preface v
Contributors ix
1 Improving Toxicity Screening and Drug Development by Using Genetically Defined Strains Michael F.W. Festing 1
2 The Sophisticated Mouse: Protecting a Precious Reagent Michael V. Wiles Rob A. Taft 23
3 Genetically Engineered Mouse Models in Drug Discovery Research Rosalba Sacca Sandra J. Engle Wenning Qin Jeffrey L. Stock John D. McNeish 37
4 Engineering the Mouse Genome to Model Human Disease for Drug Discovery Frank Koentgen Gabriele Suess Dieter Naf 55
5 Profiling of Drug Action Using Reporter Mice and Molecular Imaging Gianpaolo Rando Andrea Biserni Paolo Ciana Adriana Maggi 79
6 Human FcRn Transgenic Mice for Pharmacokinetic Evaluation of Therapeutic Antibodies Derry C. Roopenian Gregory J. Christianson Thomas J. Sproule 93
7 Development of Novel Major Histocompatibility Complex Class I and Class II-Deficient NOD-SCID IL2R Gamma Chain Knockout Mice for Modeling Human Xenogeneic Graft-Versus-Host Disease Steve Pino Michael A. Brehm Laurence Covassin-Barberis Marie King Bruce Gott Thomas H. Chase Jennifer Wagner Lisa Burzenski Oded Foreman Dale L. Greiner Leonard D. Shultz 105
8 Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans David V. Serreze Marijke Niens John Kulik Teresa P. DiLorenzo 119
9 Mouse Models of Type II Diabetes Mellitus in Drug Discovery Helene Baribault 135
10 Cholesterol Absorption and Metabolism Philip N. Howles 157
11 Collagen-Induced Arthritis in Mice Lisette Bevaart Margriet J. Vervoordeldonk Paul P. Tak 181
12 Skin Diseases in Laboratory Mice: Approaches to Drug Target Identification and Efficacy Screening John P. Sundberg Kathleen A. Silva Caroline McPhee Lloyd E. King 193
13 Models of Metastasis in Drug Discovery James E. Talmadge 215
14 Methods for Evaluating Effects of an Irinotecan + 5-Fluorouracil/Leucovorin (IFL) Regimen in an Orthotopic Metastatic Colorectal Cancer Model Utilizing In Vivo Bioluminescence Imaging David Surguladze Philipp Steiner Marie Prewett James R. Tonra 235
15 CML Mouse Model in Translational Research Cong Peng Shaoguang Li 253
16 Mouse Models for Studying Depression-Like States and Antidepressant Drugs Carisa L. Bergner Amanda N. Smolinsky Peter C. Hart Brett D. Dufour Rupert J. Egan Justin L. LaPorte Allan V. Kalueff 267
17 Virus-Delivered RNA Interference in Mouse Brain to Study Addiction-Related Behaviors Amy W. Lasek Nourredine Azouaou 283
18 Experimental Models of Anxiety for Drug Discovery and Brain Research Peter C. Hart Carisa L. Bergner Amanda N. Smolinsky Brett D. Dufour Rupert J. Egan Justin L. LaPorte Allan V. Kalueff 299
19 Mouse Models of Neurodegenerative Diseases: Criteria and General Methodology Christopher Janus Hans Welzl 323
20 Neuromuscular Disease Models and Analysis Robert W. Burgess Gregory A. Cox Kevin L. Seburn 347
21 Murine Model of Cutaneous Infection with Streptococcus pyogenes Eva Medina 395
22 Murine Model of Pneumococcal Pneumonia Eva Medina 405
23 Murine Model of Polymicrobial Septic Peritonitis Using Cecal Ligation and Puncture (CLP) Eva Medina 411
Index 417